SCHEMBL633963

SCHEMBL633963

O=CN[CH]NC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL129372 0.78
SCHEMBL3007652 0.74
SCHEMBL31332234 0.74
SCHEMBL11202100 0.70
Formaldehyde SCHEMBL4641723 0.70
SCHEMBL14157891 0.70
Formaldehyde SCHEMBL4401788 0.67
SCHEMBL1555853 0.64
SCHEMBL5139288 0.64
SCHEMBL10413427 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024062300-A1 BIODEGRADABLE ELASTOMERIC COPOLYMER SDIP Innovations Pty Ltd (AU) 2024-03-28 WO disclosed
WO-2024058975-A1 MODIFIED CHOLIC ACID CONJUGATES ULTRA, LLC (US) 2024-03-21 WO disclosed
US-20230109663-A1 CONJUGATED POLYMERS AND METHODS OF USE BioLegend, Inc. (US) 2023-04-06 US disclosed
US-11584883-B2 Conjugated polymers and methods of use BioLegend, Inc. (US) 2023-02-21 US disclosed
EP-3974496-B1 CONJUGATED POLYMERS AND METHODS OF USE BIOLEGEND INC (US) 2022-12-14 EP disclosed
US-20220002552-A1 SUBSTITUTED POLYFLUORENE COMPOUNDS BioLegend, Inc. (US) 2022-01-06 US disclosed
EP-3658648-B1 CONJUGATED POLYMERS AND METHODS OF USE BIOLEGEND INC (US) 2021-10-27 EP disclosed
US-11155714-B2 Substituted polyfluorene compounds BioLegend, Inc. (US) 2021-10-26 US disclosed
US-10988687-B2 Phthalocyanine formulation and uses thereof LI-COR, INC. (US) 2021-04-27 US disclosed
US-10757937-B2 Sulfonamides that activate ABA receptors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2020-09-01 US disclosed
US-20100323389-A1 FLUORESCENT IMAGING WITH SUBSTITUTED CYANINE DYES LI-COR, INC. (US) 2010-12-23 US disclosed
WO-2010121163-A2 FLUORESCENT IMAGING WITH SUBSTITUTED CYANINE DYES LI-COR, INC. (US) 2010-10-21 WO disclosed
US-5652247-A VASOPRESSIN ANTAGONIST OTSUKA PHARMACEUTICAL CO., LTD (JP) 1997-07-29 US disclosed
US-5436254-A Vaopressin antagonists OTSUKA PHARMACEUTICAL COMPANY, LTD. (JP) 1995-07-25 US disclosed
EP-0602209-A1 OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-06-22 EP disclosed
EP-0382185-B1 Carbostyril derivatives OTSUKA PHARMA CO LTD (JP) 1994-06-15 EP disclosed
WO-1994001113-A1 OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1994-01-20 WO disclosed
US-5225402-A Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-07-06 US disclosed
EP-0382185-A2 Carbostyril derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-08-16 EP disclosed
EP-0104157-B1 RUBBER COMPOSITIONS CONTAINING A VULCANIZATION SYSTEM ALTERATIVE Monsanto Company (US) 1986-04-02 EP disclosed